
Moderna COVID-19 Vaccine in Transplant Patients Study
Ages
Location
Compensation

COVID-19 Vaccine Trials in Phoenix
Centricity Research is currently participating in ModernaTX’s mRNA-1273 COVID-19 vaccine study at our Phoenix, AZ location. Moderna’s COVID-19 mRNA-1273 Vaccine has received Emergency Use Authorization in adults 18 years old and over from the U.S. Food and Drug Administration (FDA). The effectiveness of the mRNA-1273 study vaccine in people who have received a solid organ transplant is not known which is why we are conducting this research study.
Moderna COVID-19 Vaccine in Transplant Patients Study
The primary objective of this clinical trial is to evaluate the safety and immunogenicity of Moderna’s mRNA-1273 vaccine for the prevention of COVID-19 in participants who have had a solid organ transplant, kidney or liver.
We are specifically looking for volunteers who are:
- Adults 18 years old and over
- Kidney or liver (single organ) transplant recipients who are at least 6 months after transplantation
- Medically stable for at least 3 months prior to joining the study
As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.
Ready to Volunteer?
Volunteer today to see if you qualify for our COVID-19 vaccine clinical research study. *Qualified volunteers may be compensated for time and travel.